Real-world outcomes of stage III NSCLCs managed by surgery or definitive radiation therapy in the era of immunotherapy
Contributors
Abdelnour-Berchtold, Etienne; Chriqui, Louis-Emmanuel; Zermatten, Laetitia; Papadopoulos, Sotirios; Forster, Celine; Hasenauer, Arpad; Bedat, Benoît; Zellweger, Matthieu; Kinj, Remy; Mederos, Nuria; Christodoulou, Michel; Addeo, Alfredo; Triponez, Frédéric; Karenovics, Wolfram; Gonzalez, Michel; Krueger, Thorsten; Peters, Solange; Bouchaab, Hasna; Perentes, Jean YannisPublished in
European journal of surgical oncology, vol. 52, no. 3, 111401Publication date
2026-03First online date
2026-01-10Abstract
Keywords
- Immunotherapy
- Multidisciplinary team
- NSCLC
- Neoadjuvant
- Radiotherapy
- Surgery
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
ABDELNOUR-BERCHTOLD, Etienne et al. Real-world outcomes of stage III NSCLCs managed by surgery or definitive radiation therapy in the era of immunotherapy. In: European journal of surgical oncology, 2026, vol. 52, n° 3, p. 111401. doi: 10.1016/j.ejso.2026.111401
Main files (1)
Article (Published version)
Identifiers
- PID : unige:192246
- DOI : 10.1016/j.ejso.2026.111401
- PMID : 41604806
